phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan, for what its worth
#retatrutide 2025-07-17
Thursday20 messages4 participantstimes are UTC
Highlights from this day
- lean_mass_lex — how do people square the research use only framing with logging their own use 07:38
- panel_before_after — GI was about the same as tirzepatide for me, the difference was how fast it arrived 07:40
- peak_split — Medutest came back 99.4 on one lot and 96.8 on the next from the same ERP, both fine 08:05
- peak_split — appetite suppression at 1 was stronger than my tirzepatide experience at a comparable point 08:06
unrelated but is there any long term safety data at all or is it phase 2 and hope
glucagon is the new bit
🤝4💀9
does the energy expenditure claim show up as anything you can feel
i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind
low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom
i said 2 months ago that my heart rate had settled and it has stayed settled since
how do people square the research use only framing with logging their own use
🤝4🧪9
GI was about the same as tirzepatide for me, the difference was how fast it arrived
😂15🙏1
anyone compared their Medutest purity across two different GL Biochem lots
nobody should read my log as a plan, im recording what i did and thats all it is
phase 2 only
anyone logging resting heart rate on this
triple agonist yeah
🎉4
Medutest came back 99.4 on one lot and 96.8 on the next from the same ERP, both fine
appetite suppression at 1 was stronger than my tirzepatide experience at a comparable point
❤️7
cant feel it honestly
no long term data
research use only is on every vial and i treat it as exactly that, nobody here is prescribing
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, anyway